CAR T-Cells in the Treatment Landscape of Mantle Cell Lymphoma – Targeted Oncology
Targeted Oncology |
CAR T-Cells in the Treatment Landscape of Mantle Cell Lymphoma
Targeted Oncology Owen O'Connor, MD, PhD, director of the Center for Lymphoid Malignancies at New York-Presbyterian Hospital, discusses the possibility of using chimeric antigen receptor (CAR) T-cell therapies for the treatment of patients with mantle cell lymphoma (MCL … |
